Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05433220 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova

Study acronym: PROMPTHF-Inova
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jun 2026 to Jun 2027
    • Study completion date: Aug 2026 to Aug 25, 2027
    v7
  2. Primary completion date: Jun 2025 to Jun 2026v6
  3. Re-verified, no change to tracked fieldsv5
  4. Primary completion date: Jun 2024 to Jun 2025
    • Study completion date: Aug 2024 to Aug 2026
    v4
  5. Primary completion date: Aug 2023 to Jun 2024v3
  6. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 2022 to Aug 25, 2022
    • Secondary endpoints: 1 to 4
    • Eligibility criteria expanded, about 3 words
    • Collaborators shortened, about 3 words
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A randomized, single-blind intervention trial to test the comparative effectiveness of an electronic health record best practice advisory system that informs clinicians of guideline-indicated and FDA-approved heart failure medications currently not prescribed to their patients with heart failure versus usual care (no alert and how things are done currently). The purpose of the alert is to stimulate appropriate medication prescription for patients with heart failure and a reduced ejection fraction. This will be done across outpatient Inova clinics and at the five Inova hospitals.
Trial Details
NCT Number NCT05433220
Lead Sponsor Inova Health Care Services
Conditions
(from sponsor)		 Heart Failure
Related terms Heart Failure
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov